A2AR-phospho-STAT1 (Y701)-HLA-E axis as a potential immune modulatory pathway in radiotherapy-resistant triple negative breast cancer
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgaf069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Young Shin Ko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Institute of Medical Sciences, Gyeongsang National University, Jinjudaero 816 Bungil 15, Jinju 52727…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, STAT1 Transcription Factor, Histocompatibility Antigens Class I, Radiation Tolerance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) patients have lower survival rates and higher recurrence risks than non-TNBC patients. Moreover, radiotherapy-resistant TNBC (RT-R-TNBC) exhibits enhanced chemotherapy resistance and invasiveness. Therefore, there is a critical need for innovative treatments for RT-R-TNBC and TNBC patients. Our previous study indicated that NK cells exhibit reduced cytotoxicity against RT-R-TNBCs due to human leukocyte antigen class I histocompatibility antigen, alpha chain E (HLA-E) upregulation. Thus, this study aimed to identify the mechanism responsible for the upregulation of HLA-E and suggest potential therapeutic targets for overcoming the RT-resistance of TNBC. We found that HLA-E expression was significantly higher in TNBC tumor tissues than in normal epithelial tissues and non-TNBC tissues, correlating with A2AR levels. In addition, MDA-MB-231 (TNBC) and RT-R-MDA-MB-231 (RT-R-TNBC) showed an A2AR-dependent HLA-E overexpression. NK cell-mediated cytotoxicity against MDA-MB-231 and RT-R-MDA-MB-231 was reduced and restored by A2AR or STAT1 knockdown. Interestingly, STAT1 phosphorylation (Y701) by adenosine (ADO) aligned with the HLA-E expression pattern by ADO, and fludarabine, a STAT1 inhibitor, effectively reduced phospho-STAT1 (Y701) levels but not phospho-STAT1 (S727) levels. Fludarabine also inhibited ADO-induced HLA-E expression in MDA-MB-231 and RT-R-MDA-MB-231, including basal HLA-E expression in RT-R-MDA-MB-231. Additionally, fludarabine reduced tumor progression, lung metastasis, HLA-E expression, and phospho-STAT1 (Y701) in RT-R-MDA-MB-231-injected mice. Moreover, monalizumab, an NKG2A monoclonal antibody, significantly reduced tumor progression and lung metastasis with increased population of cytotoxic NK cells (CD25 + NK1.1+ and CD69 + NK1.1+) in the inguinal lymph nodes of RT-R-MDA-MB-231-injected mice. This study suggests that the A2AR-phospho-STAT1 (Y701)-HLA-E axis may serve as an alternative target for overcoming RT-resistance in TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Medicine, Institute of Medical Sciences, Gyeongsang National University, Jinjudaero 816 Bungil 15, Jinju 52727, Republic of Korea.
- Department of Convergence Medical Science, Gyeongsang National University, Jinjudaero 816 Bungil 15, Jinju 52727, Republic of Korea.
- College of Medicine, Gyeongsang National University, Jinjudaero 816 Bungil 15, Jinju 52727, Republic of Korea.
- Department of Pathology, College of Medicine, Institute of Medical Sciences, Gyeongsang National University, Jinjudaero 816 Bungil 15, Jinju 52727, Republic of Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, College of Medicine, Gyeongsang National University Hospital, Gyeongsang National University, Jinjudaero 816 Bungil 15, Jinju 52727, Republic of Korea.
ORCID-Profile: Young Shin Ko, Hana Jin, So Eun Lee, Ju Yeong Won, Ju Heon Lee, Jong Sil Lee, Dong Chul Kim, Seung Pil Yun, Sang Won Park, Gyeong Won Lee, Hye Jung Kim
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Ko, Y. S., Jin, H., Lee, S. E., Won, J. Y., Lee, J. H., Lee, J. S., Kim, D. C., Yun, S. P., Park, S. W., Lee, G. W., & Kim, H. J. (2025). A2AR-phospho-STAT1 (Y701)-HLA-E axis as a potential immune modulatory pathway in radiotherapy-resistant triple negative breast cancer. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf069
Vancouver
Ko YS, Jin H, Lee SE, Won JY, Lee JH, Lee JS, et al. A2AR-phospho-STAT1 (Y701)-HLA-E axis as a potential immune modulatory pathway in radiotherapy-resistant triple negative breast cancer. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf069
BibTeX
@article{Ko2025,
author = {Ko, Young Shin and Jin, Hana and Lee, So Eun and Won, Ju Yeong and Lee, Ju Heon and Lee, Jong Sil and Kim, Dong Chul and Yun, Seung Pil and Park, Sang Won and Lee, Gyeong Won and Kim, Hye Jung},
title = {A2AR-phospho-STAT1 (Y701)-HLA-E axis as a potential immune modulatory pathway in radiotherapy-resistant triple negative breast cancer},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgaf069}
}
EUVIMED